0001615186-16-000006.txt : 20160811 0001615186-16-000006.hdr.sgml : 20160811 20160811183610 ACCESSION NUMBER: 0001615186-16-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160811 FILED AS OF DATE: 20160811 DATE AS OF CHANGE: 20160811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCall Thomas D CENTRAL INDEX KEY: 0001615186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 161825811 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2016-08-11 0 0000883984 ICU MEDICAL INC/DE ICUI 0001615186 McCall Thomas D 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President and Gen'l Mgr. Common Stock 2016-08-11 4 X 0 1700.0 43.12 A 2129 D Common Stock 2016-08-11 4 S 0 1700.0 126.0314 D 429 D Common Stock 2016-08-11 4 S 0 371.0 126.2612 D 58 D Non-Qualified Stock Option (right to buy) 43.12 2016-08-11 4 X 0 1700.0 43.12 D 2015-02-02 2021-02-02 Common Stock 1700 300 D The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.98 to $126.08, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. These securities are Restricted Stock Units. Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years. Transaction is the exercise of a derivative security; see Column 2. By: Paula Darbyshire For: Thomas D. McCall 2016-08-11